Access to quality datasets is critical to ensuring the safety and efficacy of drug repurposing, precision medicine, and drug discovery. DrugBank provides free, non-commercial datasets to academic researchers, pharmacists, pharmacologists, health professionals and pharmaceutical researchers. Over the past six years approximately 1.3 million users have accessed the free public site per month from almost every country in the world.
Within the next two years, the company expects to increase annual recurring revenue by 400% and double the size of their team.
“Our ultimate goal is to contribute to medical advancements, particularly in artificial intelligence for drug discovery and repurposing, and clinical solutions such as electronic medical records software, precision medicine, and telemedicine.”
– Michael Wilson, CEO
DrugBank has accessed Alberta Innovates’ Technology Development Advisors Program since 2017. They currently receive an Alberta Innovates’ Commercialization Associates Grant (2019-2021).
DrugBank is the winner of the 2019 Startup Canada’s Prairie High-Growth Entrepreneurship Award.